• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与动静脉瘘相比,未感染的血液透析导管与炎症增加有关。

Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas.

机构信息

Baylor College of Medicine, Houston, Texas, USA.

出版信息

Kidney Int. 2009 Nov;76(10):1063-9. doi: 10.1038/ki.2009.303. Epub 2009 Aug 12.

DOI:10.1038/ki.2009.303
PMID:19675528
Abstract

Although hemodialysis catheters predispose to infection which, in turn, causes inflammation, we studied whether they induce inflammation independent of infection. We compared the level of the inflammatory marker C-reactive protein (CRP) in maintenance hemodialysis patients, comparing those dialyzed using a non-infected catheter to those using arteriovenous fistulas. All incident patients had catheters and fistula placement at dialysis initiation. In 35 patients the fistulas matured, the catheters were removed and the patients were evaluated at 6 months (catheter-fistula). These results were compared to 15 patients in whom the fistula did not mature and catheter use persisted for 6 months (catheter-catheter). There was a significant 82% reduction in the CRP level in the catheter-fistula group but a 16% increase in the catheter-catheter group at 6 months. The changes in CRP did not differ by gender, diabetes status, or by race, and was not correlated with a change in phosphorus, age, or urea reduction ratio at 1 month following hemodialysis initiation. Decreased CRP was associated with increased hemoglobin and albumin. Patients with persistent fistula use from dialysis initiation through 6 months had consistently low CRP levels over that time period. Our study shows that catheters might contribute to increased inflammation independent of infection, and supports avoidance of catheters and a timely conversion to fistulas with catheter removal.

摘要

尽管血液透析导管容易引起感染,而感染又会导致炎症,但我们研究了它们是否在不感染的情况下引发炎症。我们比较了维持性血液透析患者的炎症标志物 C 反应蛋白(CRP)水平,比较了使用未感染导管透析的患者与使用动静脉瘘的患者。所有新发病例在透析开始时均放置了导管和瘘管。在 35 例患者中,瘘管成熟,导管被移除,患者在 6 个月时进行评估(导管-瘘管)。将这些结果与 15 例瘘管未成熟且导管使用持续 6 个月的患者(导管-导管)进行比较。导管-瘘管组的 CRP 水平显著降低了 82%,而导管-导管组则增加了 16%。CRP 的变化与性别、糖尿病状态或种族无关,与透析开始后 1 个月磷、年龄或尿素清除率的变化无关。CRP 的降低与血红蛋白和白蛋白的增加有关。从透析开始到 6 个月期间持续使用瘘管的患者在此期间 CRP 水平持续较低。我们的研究表明,导管可能会在不感染的情况下导致炎症增加,并支持避免使用导管,并及时将导管转换为瘘管以去除导管。

相似文献

1
Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas.与动静脉瘘相比,未感染的血液透析导管与炎症增加有关。
Kidney Int. 2009 Nov;76(10):1063-9. doi: 10.1038/ki.2009.303. Epub 2009 Aug 12.
2
Level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with non-infected catheters and arteriovenous fistula in a large Saudi hemodialysis center.慢性血液透析患者的C反应蛋白水平:沙特一家大型血液透析中心非感染导管患者与动静脉内瘘患者的比较研究
Ther Apher Dial. 2013 Feb;17(1):35-9. doi: 10.1111/j.1744-9987.2012.01116.x. Epub 2012 Oct 30.
3
The level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with noninfected catheters and arteriovenous fistula in two large Gulf hemodialysis centers.慢性血液透析患者的C反应蛋白水平:两个大型海湾血液透析中心非感染导管患者与动静脉内瘘患者的比较研究
Hemodial Int. 2014 Jul;18(3):674-9. doi: 10.1111/hdi.12145. Epub 2014 Jan 27.
4
Utilization, patency, and complications associated with vascular access for hemodialysis in the United States.美国血液透析血管通路的利用、通畅性和相关并发症。
J Vasc Surg. 2018 Oct;68(4):1166-1174. doi: 10.1016/j.jvs.2018.01.049.
5
Arteriovenous fistulas ipsilateral to internal jugular catheters for hemodialysis have decreased patency rates.用于血液透析的颈内静脉导管同侧的动静脉瘘通畅率降低。
Vascular. 2019 Jun;27(3):270-276. doi: 10.1177/1708538118811483. Epub 2018 Nov 19.
6
Association of vascular access type with inflammatory marker levels in maintenance hemodialysis patients.维持性血液透析患者血管通路类型与炎症标志物水平的关联
Semin Dial. 2014 Jul-Aug;27(4):415-23. doi: 10.1111/sdi.12146. Epub 2013 Oct 9.
7
Do AV fistulas contribute to cardiac mortality in hemodialysis patients?动静脉内瘘会导致血液透析患者的心脏死亡吗?
Semin Dial. 2002 Jan-Feb;15(1):14-7. doi: 10.1046/j.1525-139x.2002.00003.x.
8
Primary arteriovenous fistulas in the forearm for hemodialysis: effect of miscellaneous factors in fistula patency.用于血液透析的前臂原发性动静脉内瘘:多种因素对瘘管通畅性的影响
Ren Fail. 2006;28(4):275-81. doi: 10.1080/08860220600583617.
9
Change in vascular access and mortality in maintenance hemodialysis patients.维持性血液透析患者血管通路的变化与死亡率
Am J Kidney Dis. 2009 Nov;54(5):912-21. doi: 10.1053/j.ajkd.2009.07.008. Epub 2009 Sep 12.
10
C-reactive protein and dialysis access.C 反应蛋白与透析通路。
Kidney Int. 2009 Nov;76(10):1025-6. doi: 10.1038/ki.2009.301.

引用本文的文献

1
A meta-analysis of the impact of initial hemodialysis access type on mortality in elderly incident hemodialysis population.初始血液透析通路类型对老年初治血液透析人群死亡率影响的荟萃分析。
BMC Geriatr. 2025 Mar 19;25(1):186. doi: 10.1186/s12877-025-05696-0.
2
Fistula first, catheter last: can the mouth be second?先造瘘,后置管:口腔能排第二吗?
Front Nephrol. 2024 May 23;4:1385544. doi: 10.3389/fneph.2024.1385544. eCollection 2024.
3
The efficacy and safety of molidustat for anemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A systematic review and meta-analysis.
莫利度司他治疗依赖透析和非依赖透析的慢性肾病患者贫血的疗效和安全性:一项系统评价和荟萃分析。
Heliyon. 2024 May 4;10(9):e30621. doi: 10.1016/j.heliyon.2024.e30621. eCollection 2024 May 15.
4
Machine learning models using non-linear techniques improve the prediction of resting energy expenditure in individuals receiving hemodialysis.机器学习模型采用非线性技术提高了血液透析个体静息能量消耗预测的准确性。
Ann Med. 2023;55(2):2238182. doi: 10.1080/07853890.2023.2238182.
5
Persistent Increase in Serum Ferritin Levels despite Converting to Permanent Vascular Access in Pediatric Hemodialysis Patients: Pediatric Nephrology Research Consortium Study.尽管小儿血液透析患者已转换为永久性血管通路,但血清铁蛋白水平仍持续升高:小儿肾脏病研究联盟研究
J Clin Med. 2023 Jun 25;12(13):4251. doi: 10.3390/jcm12134251.
6
Responsiveness to an erythropoiesis-stimulating agent is correlated with body composition in patients undergoing chronic hemodialysis.接受慢性血液透析的患者对促红细胞生成素的反应性与身体组成相关。
Front Nutr. 2022 Dec 2;9:1044895. doi: 10.3389/fnut.2022.1044895. eCollection 2022.
7
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.接受血液透析的患者通常会对红细胞生成刺激剂产生短暂的耐药性。
Am J Nephrol. 2022;53(5):333-342. doi: 10.1159/000523947. Epub 2022 Apr 22.
8
Management of Central Venous Stenosis and Occlusion in Dialysis Patients.透析患者中心静脉狭窄和闭塞的管理
Semin Intervent Radiol. 2022 Feb 18;39(1):51-55. doi: 10.1055/s-0041-1742152. eCollection 2022 Feb.
9
Challenging patient phenotypes in the management of anaemia of chronic kidney disease.慢性肾脏病贫血管理中的挑战性患者表型。
Int J Clin Pract. 2021 Nov;75(11):e14681. doi: 10.1111/ijcp.14681. Epub 2021 Aug 12.
10
Influence of Tunneled Hemodialysis-Catheters on Inflammation and Mortality in Dialyzed Patients.经皮隧道式血液透析导管对透析患者炎症和死亡率的影响。
Int J Environ Res Public Health. 2021 Jul 16;18(14):7605. doi: 10.3390/ijerph18147605.